Cantor Fitzgerald Investment Advisors’s Elevance Health ELV Stock Holding History

Cantor Fitzgerald Investment Advisors’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.53M	Buy	3,960 +90	+2%	+$33.4K	0.1%	116
2026 Q1	$1.13M	Sell	3,870 -475	-11%	-$156K	0.08%	121
2025 Q4	$1.52M	Sell	4,345 -165	-4%	-$55.8K	0.11%	113
2025 Q3	$1.46M	Buy	+4,510	New	+$1.4M	0.1%	125
2022 Q1	$481K	Buy	980 +475	+94%	+$217K	0.02%	258
2021 Q4	$234K	Buy	+505	New	+$212K	0.01%	292

Other funds holding ELV

AACR

ACR Alpine Capital Research St. Louis, Missouri $7.04B AUM 28% 1-Year Est. Return

HGIM

High Ground Investment Management London, United Kingdom $1.14B AUM 29.32% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Focused Investors Los Angeles, California $2.96B AUM 15.6% 1-Year Est. Return

Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return

Canoe Financial Calgary, Alberta, Canada $8.07B AUM 25.47% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Cantor Fitzgerald Investment Advisors's ELV Position: Q2 2026 in Review

Cantor Fitzgerald Investment Advisors increased its Elevance Health (ELV) stake by 2.3% in Q2 2026, buying an estimated $33.4K and bringing the position to 3,960 shares worth $1.53M. The position accounts for 0.1% of the portfolio, ranked #116.

Cantor Fitzgerald Investment Advisors first reported a position in ELV in Q4 2021 and has held it in 6 quarters since. 637 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

Cantor Fitzgerald Investment Advisors held 3,960 shares of Elevance Health worth $1.53M as of Q2 2026.
Cantor Fitzgerald Investment Advisors bought 90 Elevance Health shares in Q2 2026, an estimated $33.4K.
Elevance Health made up 0.1% of Cantor Fitzgerald Investment Advisors's portfolio in Q2 2026, its #116 holding.
Cantor Fitzgerald Investment Advisors first reported a position in Elevance Health in Q4 2021 and has held it in 6 quarters since.
637 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Cantor Fitzgerald Investment Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.